Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
achieved, Array, blinded, condensed, conform, directly, dramatically, effort, encouraging, factor, Gilford, HTVN, immunogenicity, larger, member, person, promising, reclassified, reproducible, serve, SIV, sponsored, supplemental, therapy
Removed:
accrued, amendment, authorized, certificate, Chairman, closing, contract, determined, efficacy, enacted, FDA, February, governmental, impacted, improve, incorporation, initiation, investigate, investor, July, leading, made, range, recently, registration, restated, retroactively, reverse, sell, settlement, specific, split, statement, work
Filing tables
Filing exhibits
GOVX similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of GeoVax Labs, Inc. (the "Company") on Form 10-Q for the three months ended March 31, 2011, I, Mark W. Reynolds, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002, that to the best of my knowledge:
1. The quarterly report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
2. The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: April 27, 2011 | /s/ Mark W. Reynolds | ||
Mark W. Reynolds | |||
Chief Financial Officer | |||